ArticleJournal of anesthesia2026
Effect of flurbiprofen on intraoperative nausea and vomiting during cesarean delivery: a single-center retrospective cohort study.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- In reply to: comment on "Effect of flurbiprofen on intraoperative nausea and vomiting during cesarean delivery: a single-center retrospective cohort study".Journal of anesthesia · 2026Article
- Comment on "Effect of flurbiprofen on intraoperative nausea and vomiting during cesarean delivery: a single-center retrospective cohort study".Journal of anesthesia · 2026Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIntraoperative nausea and vomiting are common during cesarean delivery under neuraxial anesthesia, and peritoneal traction is a major trigger. Flurbiprofen, a non-steroidal anti-inflammatory drug used for multimodal analgesia, is typically administered toward the end of surgery; whether earlier intraoperative administration is associated with reduced intraoperative nausea and vomiting remains unclear.
methodsWe conducted a retrospective cohort study at a single tertiary university hospital in Japan from October 1, 2021 to September 30, 2025. Parturients undergoing cesarean delivery under neuraxial anesthesia were classified as an early group (intravenous flurbiprofen administered after umbilical cord clamping and by the start of peritoneal closure) or a non-early group (administered after the start of peritoneal closure or not administered intraoperatively). The primary outcome was intraoperative antiemetic use, pre-specified as a surrogate for intraoperative nausea and vomiting. Adjusted odds ratios were estimated using multivariable logistic regression with pre-specified sensitivity analyses.
resultsA total of 1398 parturients were included (early, n = 1062; non-early, n = 336). Intraoperative antiemetic use occurred in 172/1,062 (16.2%) and 91/336 (27.1%), respectively, corresponding to an absolute risk difference of - 10.9 percentage points. Early flurbiprofen administration was associated with lower odds of intraoperative antiemetic use (adjusted odds ratio 0.54; 95% confidence interval 0.41 to 0.73; P < 0.001), with consistent findings across sensitivity analyses.
conclusionEarly intraoperative flurbiprofen administration after umbilical cord clamping was associated with lower intraoperative antiemetic use during cesarean delivery under neuraxial anesthesia, suggesting that the timing of routine non-steroidal anti-inflammatory drug administration may be relevant to intraoperative nausea and vomiting management.
Indexed as
Identifiers
42159676What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.